國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Coronavirus disease - COVID-19

Rezaei, Nima.

Coronavirus disease - COVID-19

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Coronavirus disease - COVID-19edited by Nima Rezaei.
其他作者:	Rezaei, Nima.
出版者:	Cham :Springer International Publishing :2021.
面頁冊數:	xx, 964 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	COVID-19 (Disease)
電子資源:	https://doi.org/10.1007/978-3-030-63761-3
ISBN:	9783030637613$q(electronic bk.)

Coronavirus disease - COVID-19
Coronavirus disease - COVID-19[electronic resource] /edited by Nima Rezaei. - Cham :Springer International Publishing :2021. - xx, 964 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology,v.13180065-2598 ;. - Advances in experimental medicine and biology ;946..

In December 2019, the world witnessed the occurrence of a new coronavirus to humanity. The disease spread quickly and became known as a pandemic globally, affecting both society and the health care system, both the elderly and young groups of people, and both the men's and women's groups. It was a universal challenge that immediately caused a surge in scientific research. Be a part of a world rising in fighting against the pandemic, the Coronavirus Disease - COVID-19 was depicted in the early days of the pandemic, but updated by more than 200 scientists and clinicians to include many facets of this new infectious pandemic, including i, characteristics, ecology, and evolution of coronaviruses; ii, epidemiology, genetics, and pathogenesis (immune responses and oxidative stress) of the disease; iii, diagnosis, prognosis, and clinical manifestations of the disease in pediatrics, geriatrics, pregnant women, and neonates; iv, challenges of co-occurring the disease with tropical infections, cardiovascular diseases, hypertension, and cancer and to the settings of dentistry, hematology, ophthalmology, and pharmacy; v, transmission, prevention, and potential treatments, ranging from supportive ventilator support and nutrition therapy to potential virus- and host-based therapies, immune-based therapies, photobiomodulation, antiviral photodynamic therapy, and vaccines; vi, the resulting consequences on social lives, mental health, education, tourism industry and economy; and vii, multimodal approaches to solve the problem by bioinformatic methods, innovation and ingenuity, globalization, social and scientific networking, interdisciplinary approaches, and art integration. We are approaching December 2020 and the still presence of COVID-19, asking us to call it COVID (without 19)

ISBN: 9783030637613$q(electronic bk.)

Standard No.: 10.1007/978-3-030-63761-3doiSubjects--Topical Terms:

877725
COVID-19 (Disease)

LC Class. No.: RA644.C67 / C67 2021

Dewey Class. No.: 614.592414

Coronavirus disease - COVID-19
LDR:02835nmm a2200325 a 4500 001 598281
003 DE-He213
005 20210511011548.0
006 m d
007 cr nn 008maaau
008 211025s2021 sz s 0 eng d
020 $a 9783030637613$q(electronic bk.)
020 $a 9783030637606$q(paper)
024 7 $a 10.1007/978-3-030-63761-3 $2 doi
035 $a 978-3-030-63761-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RA644.C67 $b C67 2021
072 7 $a MMFM $2 bicssc
072 7 $a MED052000 $2 bisacsh
072 7 $a MKFM $2 thema
082 0 4 $a 614.592414 $2 23
090 $a RA644.C67 $b C822 2021
245 0 0 $a Coronavirus disease - COVID-19 $h [electronic resource] / $c edited by Nima Rezaei.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a xx, 964 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology, $x 0065-2598 ; $v v.1318
520 $a In December 2019, the world witnessed the occurrence of a new coronavirus to humanity. The disease spread quickly and became known as a pandemic globally, affecting both society and the health care system, both the elderly and young groups of people, and both the men's and women's groups. It was a universal challenge that immediately caused a surge in scientific research. Be a part of a world rising in fighting against the pandemic, the Coronavirus Disease - COVID-19 was depicted in the early days of the pandemic, but updated by more than 200 scientists and clinicians to include many facets of this new infectious pandemic, including i, characteristics, ecology, and evolution of coronaviruses; ii, epidemiology, genetics, and pathogenesis (immune responses and oxidative stress) of the disease; iii, diagnosis, prognosis, and clinical manifestations of the disease in pediatrics, geriatrics, pregnant women, and neonates; iv, challenges of co-occurring the disease with tropical infections, cardiovascular diseases, hypertension, and cancer and to the settings of dentistry, hematology, ophthalmology, and pharmacy; v, transmission, prevention, and potential treatments, ranging from supportive ventilator support and nutrition therapy to potential virus- and host-based therapies, immune-based therapies, photobiomodulation, antiviral photodynamic therapy, and vaccines; vi, the resulting consequences on social lives, mental health, education, tourism industry and economy; and vii, multimodal approaches to solve the problem by bioinformatic methods, innovation and ingenuity, globalization, social and scientific networking, interdisciplinary approaches, and art integration. We are approaching December 2020 and the still presence of COVID-19, asking us to call it COVID (without 19)
650 0 $a COVID-19 (Disease) $3 877725
650 0 $a COVID-19 Pandemic, 2020- $3 890299
650 0 $a Virology. $3 196498
650 0 $a Immunology. $3 189152
650 0 $a Epidemiology. $3 191577
700 1 $a Rezaei, Nima. $3 591948
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a Advances in experimental medicine and biology ; $v 946. $3 557559
856 4 0 $u https://doi.org/10.1007/978-3-030-63761-3
950 $a Biomedical and Life Sciences (SpringerNature-11642)